This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
CD30/TNFRSF8 Antibody (CD30/412)
catalog :
NBP2-29425
quantity :
0.1 mg (also 20 ug)
price :
429 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
CD30/412
reactivity :
human
application :
immunohistochemistry, immunohistochemistry - paraffin section
citations: 1
Reference
Hartmann S, Scharf S, Steiner Y, Loth A, Donnadieu E, Flinner N, et al. Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas. Cancers (Basel). 2021;13: pubmed publisher
product information
brand :
Novus Biologicals, a Bio-Techne brand
catalog number base :
NBP2-29425
SKU :
NBP2-29425
product name :
CD30/TNFRSF8 Antibody (CD30/412)
description :
The CD30/TNFRSF8 Antibody (CD30/412) from Novus Biologicals is a mouse monoclonal antibody to CD30/TNFRSF8. This antibody reacts with human. The CD30/TNFRSF8 Antibody (CD30/412) has been validated for the following applications: Immunohistochemistry,Immunohistochemistry-Paraffin.
target :
CD30/TNFRSF8
unit size :
0.1 mg (also 20 ug)
category :
Primary Antibodies
buffer :
10 mM PBS with 0.05% BSA
clonality :
Monoclonal
clone :
CD30/412
concentration :
0.2 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
Human CD30/TNFRSF8 recombinant protein (Uniprot: P28908)
isotype :
IgG1 Kappa
marker :
Hodgkin & Reed-Sternberg Cell Marker
purity :
Protein A or G purified
species :
Human
specificity :
Recognizes a single chain glycoprotein of 105/120kDa, identified as CD30/Ki-1
storage :
Store at 4C.
gene symbol :
TNFRSF8
accessionNumbers :
P28908, P28908, P28908
applications :
Immunohistochemistry,Immunohistochemistry-Paraffin
USD :
419
USD 2025 :
429 USD
alt names :
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.